The Australia New Zealand Gynaecological Oncology Group is the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand.
Their purpose is to improve outcomes and quality of life for women with gynaecological cancer through conducting and promoting cooperative clinical trials and undertaking multidisciplinary research into the causes, prevention and treatments of gynaecological cancer.
ANZGOG was established in 2000. Their 940+ members include clinicians who treat women with gynaecological cancer, nurses, laboratory researchers and women with cancer. They conduct research with over 52 hospitals and many research and academic institutions. ANZGOG is active in all states and most territories of Australia; and New Zealand.
“Our team from the Westmead Institute for Medical Research in Sydney, and the Peter McCallum Cancer Centre in Melbourne, has a major focus on understanding LGSC and finding new and effective treatment options.”…”In partnership with ANZGOG, we are in the advanced stages of planning a much larger clinical trial to test a new combination we predict will be effective…” Read more from Australian professor Anna deFazio on LGSC research in Australia.